Standing Order Vs Collaborative Practice Agreement

According to health researcher Karen E. Koch, the first initiative of “collaborative management of drug therapy” can be attributed to William A. Zellmers in 1995 in the American Journal of Health-System Pharmacy. [4] Zellmer argues for the use of the term “collaborative management of drug therapy” instead of “prescription,” and argues that this will make laws that expand the authority of pharmacists tastier for legislators (and physician representatives). The most important is the debate on why pharmacists are interested in extending this authority: improving patient care through interdisciplinary cooperation. [5] The modern concept of collaborative practice has been partly derived from the controversial notion of dependent prescribing authority. [4] The term “cooperation agreement” has also been called a consultation agreement, a collaborative pharmacy practice agreement, a physician-pharmacist agreement, a permanent mandate or permanent protocol and a physician`s delegation. [6] A Collaborative Practice Agreement is a legal document in the United States that establishes a formal relationship between pharmacists (often clinical pharmacy specialists) and cooperating physicians, in order to create a legal and ethical basis for pharmacists involved in collaborative therapy management. [7] [4] State: Arizona 3rd Party: Yes Standing Order: Yes Pharmacy Access Notes: Statewide Standing Order from State Health Officer allows pharmacists to distribute naloxone to anyone without a prescription. Other resources: CDTM is an extension of the traditional practice of pharmacists that allows for pharmacist-managed management of drug-related problems (DOP), with a focus on a collaborative and interdisciplinary approach to pharmacy practices in the health field.

The conditions of a CPA are defined by the pharmacist and the cooperating physician, although models exist online. CPAs may be specific to a patient population of interest to both parties, a specific clinical situation or disease, and/or a factual protocol for managing the drug treatment of patients under CPA. CPAs have been the subject of intensive debate in pharmacy and medicine. CPAs originated in Washington in 1979, notes a report by the National Alliance of State Pharmacy Association (NASPA) with the passage of the Pharmacy Practice Act. The report also notes that in August 2018, 48 states and the District of Columbia authorized the Community Authority for Pharmacists and Prescriptions, as prescription authorities were unable to delegate CPA authority in Alabama and Delaware to pharmacists. The Federal Law on the Status of Pharmacists was introduced in the United States